In the high-stakes world of pharmaceutical marketing, navigating the industry's complex regulatory environment requires knowledge and precision. The slightest deviation from established standards can ...

Amber Nigam is CEO and cofounder of basys.ai, a Harvard-based company streamlining prior authorization for health plans with generative AI. The pharmaceutical industry is at a significant crossroads, ...

LaMattina is the former president of Pfizer Global R&D and is currently a senior director at PureTech Health. In July 2006, The New York Times sent young reporter Alex Berenson to Pfizer to interview ...

The Fast Company Executive Board is a private, fee-based network of influential leaders, experts, executives, and entrepreneurs who share their insights with our audience. BY Maria Alonso ...

Around 1990, a bright, young Harvard academic became interested in the possibility that a relatively unknown peptide might slow gastric emptying and reduce hunger — a potential boon to the treatment ...

In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $467.35, marking a +1.35% move from the previous day.

AI has infiltrated seemingly every facet of business over the last year. The pharmaceutical industry is no different, and this technology’s rapid evolution can change drug development forever. However ...

What is Pharma 4.0? The term Industry 4.0 refers to the fourth industrial revolution, associated with the application of advanced technologies that have dramatically changed the landscape of ...

As a central pillar of modern society, the pharmaceutical industry bears the load of billions of lives around the world. In 2022, the global revenue of the pharmaceutical industry approximated $1.5 ...

In a major boost to the Indian bulk drugs industry, Indian pharma industry and exporters will discuss the production linked incentive (PLI) scheme for active pharmaceutical ingredients (APIs) with the ...